Royal

Low-Income Housing Investments Ramping Up at Freddie Mac as FHFA Increases LIHTC Equity Cap to $850 Million

Retrieved on: 
水曜日, 9月 1, 2021

MCLEAN, Va., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) will begin ramping up its Low-Income Housing Tax Credit (LIHTC) equity investments, which support affordable housing throughout the United States.

Key Points: 
  • MCLEAN, Va., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) will begin ramping up its Low-Income Housing Tax Credit (LIHTC) equity investments, which support affordable housing throughout the United States.
  • The move comes in response to the Federal Housing Finance Agencys (FHFA) announcement that it has increased the annual cap on Freddie Macs LIHTC Equity investments from $500 million to $850 million.
  • Freddie Mac has provided approximately $500 million in LIHTC Equity investments each year since reentering the market in 2018.
  • Freddie Macs LIHTC Equity investments already support affordable housing throughout the United States.

Global Dairy Platform Announces New Board Chair

Retrieved on: 
火曜日, 8月 31, 2021

ROSEMONT, Ill., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Global Dairy Platform (GDP), a not-for-profit industry association representing the international dairy sector, today announced the appointment of Hein Schumacher, Chief Executive Officer of Royal FrieslandCampina, as Chair of GDPs Board of Directors.

Key Points: 
  • ROSEMONT, Ill., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Global Dairy Platform (GDP), a not-for-profit industry association representing the international dairy sector, today announced the appointment of Hein Schumacher, Chief Executive Officer of Royal FrieslandCampina, as Chair of GDPs Board of Directors.
  • Schumacher succeeds Rick Smith, President and Chief Executive Officer of Dairy Farmers of America, who completed a four-year term as GDP Chair.
  • I am honored to serve as Chair of GDP and build on the momentum that Rick, supported by the Board of Directors, has established, Schumacher said.
  • The future is bright for GDP and the global dairy sector, he added.

Genetic Testing Pioneer DnaNudge Announces Completion of $60 Million Series A Investment Led by Ventura Capital

Retrieved on: 
火曜日, 8月 31, 2021

Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has successfully completed a $60 million Series A investment round led by investment company Ventura Capital.

Key Points: 
  • Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has successfully completed a $60 million Series A investment round led by investment company Ventura Capital.
  • DnaNudge is also providing CovidNudge testing as a private consumer service and is playing a key role in the safe return of the UKs cultural sector.
  • The gold-standard RT-PCR platform brought to market by DnaNudge is a quantum leap in terms of PCR testing time, cost and ease.
  • Powered by this investment, DnaNudge is well-positioned to become the new standard for disease testing globally.

PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services

Retrieved on: 
木曜日, 8月 26, 2021

NANJING, China, Aug. 26, 2021 /PRNewswire/ -- PharmaBlock (300725.SZSE), an innovative chemistry products and services provider to support drug discovery, development, and commercialization, announces the appointment of Dr. Xudong Wei as Senior Vice President and Head of CDMO Business to enhance small molecule CDMO capabilities and speed up the business.

Key Points: 
  • NANJING, China, Aug. 26, 2021 /PRNewswire/ -- PharmaBlock (300725.SZSE), an innovative chemistry products and services provider to support drug discovery, development, and commercialization, announces the appointment of Dr. Xudong Wei as Senior Vice President and Head of CDMO Business to enhance small molecule CDMO capabilities and speed up the business.
  • The appointments demonstrate the priority that PharmaBlock places on attracting vital talents to lead and innovate essential CMC functions.
  • In 2020, Dr. Wenfang Miao joined PharmaBlock as Senior Vice President of Quality.
  • PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process and commercial production.

BIG3 Brings The Fire As It Announces Legendary Matchups And Broadcasting Lineup Ahead Of Playoffs This Saturday, August 28 In The Bahamas

Retrieved on: 
水曜日, 8月 25, 2021

Julius "Dr. J" Erving's Tri-State will then face Stephen Jackson's Trilogy in a head-to-head battle in the second game.

Key Points: 
  • Julius "Dr. J" Erving's Tri-State will then face Stephen Jackson's Trilogy in a head-to-head battle in the second game.
  • Fans can tune into the final weekend of the fourth season on CBS at 3:30pm EST on Saturday, September 4.
  • No one knows who is going to come out on top; you'll just have to tune in to find out."
  • Joe Johnson, 31)
    "I can't believe we are already preparing for the playoffs and packing our bags for The Bahamas," said BIG3 Commissioner, Clyde Drexler.

Astro Aerospace Selected for AFWERX HSVTOL Challenge

Retrieved on: 
水曜日, 8月 25, 2021

Dallas, Texas, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Astro Aerospace (OTCQB: ASDN) (Astro or the Company) has announced that its revolutionary Cavorite X5 eVTOL platform has been selected for the highly competitive AFWERX High Speed VTOL (HSVTOL) Concept Challenge (the Challenge) an initiative launched in partnership with the United States Air Force (USAF) and US Special Operations Command (USSOCOM) to explore innovative HSVTOL concepts that can support a wide range of military applications.

Key Points: 
  • Dallas, Texas, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Astro Aerospace (OTCQB: ASDN) (Astro or the Company) has announced that its revolutionary Cavorite X5 eVTOL platform has been selected for the highly competitive AFWERX High Speed VTOL (HSVTOL) Concept Challenge (the Challenge) an initiative launched in partnership with the United States Air Force (USAF) and US Special Operations Command (USSOCOM) to explore innovative HSVTOL concepts that can support a wide range of military applications.
  • Traveling up to 275 mph over 340 miles, the Cavorite X5 offers exceptional payload, speed and range ideally suited for many high-risk environments.
  • We are very proud that the Cavorite X5 was chosen for the extremely competitive AFWERX Challenge, remarked Mr. Robinson.
  • Astro Aerospace is the developer of an advanced, autonomous, short haul, eVTOL (Electric Vertical Take-off and Landing) aerial vehicles.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of RYFL, VLLX, ISBC, and STFR Buyouts

Retrieved on: 
水曜日, 8月 18, 2021

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-royal-financial-inc .

Key Points: 
  • To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-royal-financial-inc .
  • Investors Bancorp, Inc. (NASDAQ GS: ISBC ) regarding possible breaches of fiduciary duties and other violations of law related to Investors agreement to be acquired by Citizens Financial Group, Inc. (Citizens).
  • Under the terms of the agreement, Investors shareholders will receive 0.297 shares of Citizens and $1.46 in cash per share.
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected] .

UK’s Royal Opera House Sings the Praises of Nutanix Cloud Platform Software

Retrieved on: 
水曜日, 8月 18, 2021

With a large number of performances and plans to expand its digital streaming offering -- the fastest growing part of the business -- the ROH evaluated all available options, ultimately choosing the Nutanix Cloud Platform including Nutanix Prism Pro and Nutanix Calm to deliver intelligent ITOPs and automation across a multicloud environment, along with Rubrik backup and recovery-as-a-Service.

Key Points: 
  • Nutanix (NASDAQ: NTNX ), a leader in hybrid multicloud computing, today announced that its software has helped the Royal Opera House (ROH) in London to take full advantage of cloud technologies and realize benefits across its business.
  • With a history spanning more than 250 years, the ROH is the UKs only permanent house for opera and ballet, staging 420 live performances every year.
  • Organizations around the world use Nutanix software to leverage a single platform to manage any app at any location for their hybrid multicloud environments.
  • Nutanix, the Nutanix logo, and all Nutanix product and service names mentioned herein are registered trademarks or trademarks of Nutanix, Inc. in the United States and other countries.

Former Royal LePage CEO, Simon Dean joins Unreserved.com as Chairman

Retrieved on: 
火曜日, 8月 17, 2021

OTTAWA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Ryan OConnor, CEO of Unreserved.com, is pleased to announce that Simon Dean will be joining the Company as Chairman, effective immediately.

Key Points: 
  • OTTAWA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Ryan OConnor, CEO of Unreserved.com, is pleased to announce that Simon Dean will be joining the Company as Chairman, effective immediately.
  • Most recently serving as the President and CEO of Royal LePage Real Estate Services, Simon Dean brings a wealth of experience to the Unreserved management team.
  • Mr. Dean joined Royal LePage in 1995 and remained on the Board of Directors, following retirement, until 2019.
  • For Unreserved Investor Relations Inquiries, please contact:
    For Unreserved Media & PR Inquiries, please contact:
    For Sales & Customer Support, please contact:

Royal Biologics Announces Partnership With Vilex Launching Its ALC Technology Into Lower Extremity Industry

Retrieved on: 
火曜日, 8月 17, 2021

As healthcare costs continue to rise, the industry is in need ofnovel and innovative biologic technologies.

Key Points: 
  • As healthcare costs continue to rise, the industry is in need ofnovel and innovative biologic technologies.
  • The partnership between Royal Biologics and Vilex will put these products at the forefront of lower extremity orthopedic surgeries.
  • "We are extremely excited to have Vilex, a leader in lower extremity orthopedic surgery, as our partner to distribute our Autologous and Live Cellular portfolio," said Dan Schneider, Vice President of Sales at Royal Biologics.
  • Royal Biologics is an ortho-biologics and life science company specializing in the research and advancement of novel ortho-biologics solutions.